Q2 2019
Released Jul 25, 2019, after the close
10-Q filed Jul 25, 2019, 25 days after period end · 0001564590-19-026122
Q2 2019 · 10-Q
Revenue—
Net Income-$3.88M-$3.88M N/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$0.09-$0.09 N/M vs Q2 2018N/M vs Q1 2019
Operating Income-$4,182,021N/M
Operating Cash Flowderived-$1,652,310N/M
Free Cash Flowderived-$1,654,370N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$3.88M | -$3.14M | -$2.79M | -$3.20K |
| EPS Diluted | -$0.09 | -$0.08 | -$0.08 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR